Under certain conditions it is optimal for the noninnovating south to give patent protection for a longer time period than the innovating north. A cooperative patent agreement involves a larger protection by each country compared to the non-cooperative situation. [WP 9].

This paper highlights the status of the Indian biopharmaceutical industry and also makes a comparison with the global scenario. It also discusses the current situation regarding patenting biopharmaceuticals in India. [GIDR WP no. 168].